Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis.

Skolnick, C A

Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis. [electronic resource] - American journal of ophthalmology Mar 2000 - 363-6 p. digital

Publication Type: Case Reports; Journal Article

0002-9394

10.1016/s0002-9394(99)00350-5 doi


Acute Disease
Adult
Fibrin--drug effects
Fibrinolysis--drug effects
Fibrinolytic Agents--therapeutic use
Glaucoma--etiology
HLA-B27 Antigen--analysis
Humans
Iridocyclitis--blood
Male
Pupil Disorders--etiology
Tissue Plasminogen Activator--therapeutic use